Abstract

Objectives: Infants with CF (IwCF) frequently receive systemic antibiotics for increased respiratory symptoms. The effects of these treatments on CF oropharyngeal (OP) and gastrointestinal (GI) microbiota are undefined, despite the importance of bacteria in both spaces: GI microbes impact immunity and nutrition, and OP samples serve increasingly as proxies for CF lower respiratory tract microbiology. Each site could also harbor transmissible antibiotic resistance determinants. Given that IwCF are relatively naïve to antibiotics, we compared the effects of one commonly-used antibiotic class- β-lactams- on the GI and OP microbiota of IwCF treated for new respiratory symptoms.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call